@Article{Lin2023,
journal="Journal of Contemporary Brachytherapy",
issn="1689-832X",
volume="15",
number="4",
year="2023",
title="TACE combined with portal particle implantation in a case of stage IIIa primary hepatocellular carcinoma treated with sequential anlotinib",
abstract="Few cases of patients with Cheng’s type III portal vein tumor thrombus (PVTT) have been reported to achieve radical cure without recurrence over time. In this study, we reported on a 55-year-old male patient with a diagnosis of stage IIIa China liver cancer staging (CNLC), PVTT Cheng’s type III, mild cirrhosis, and chronic viral hepatitis B. TACE combined with radioactive iodine-125 ( 125 I) particle implantation was applied to achieve radical treatment with sequential oral anlotinib hydrochloride capsules. This case might serve as a reference for the treatment of this disease.",
author="Lin, Cheng
and Chen, Chen
and Huang, Guiliu
and Li, Yueyong
and Zhao, Lifeng
and Wei, Zhongheng",
pages="283--289",
doi="10.5114/jcb.2023.131239",
url="http://dx.doi.org/10.5114/jcb.2023.131239"
}